Inthera Bioscience
Latest round
- Series A
Last raised
- Jul 2018
Total raised
- $20M
Investors
- 4
About Inthera Bioscience
Founded in 2013 and headquartered in Zurich, Switzerland, Inthera Bioscience AG specializes in creating novel cancer therapies.Inthera Bioscience focuses on developing advanced biopharmaceuticals that target cancer cells by inducing replicative stress. Their innovative therapies are designed to disrupt the cancer cell cycle, improving outcomes for patients with various types of cancer.Inthera Bioscience’s revenue model is primarily based on collaborative partnerships and clinical trials, generating income through licensing agreements and partnerships with healthcare institutions and pharmaceutical companies. The company plans to develop new products targeting critical cancer pathways and expand into additional markets in Europe and North America by 2023, focusing on addressing substantial unmet needs in cancer treatment.
Who invested in Inthera Bioscience
4 investors across 3 rounds
See all investors in Inthera Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Inthera Bioscience
Who invested in Inthera Bioscience?
Inthera Bioscience has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inthera Bioscience raised?
Inthera Bioscience has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Inthera Bioscience last raise money?
Inthera Bioscience's most recent round on record is a Series A, in Jul 2018.
What does Inthera Bioscience do?
Founded in 2013 and headquartered in Zurich, Switzerland, Inthera Bioscience AG specializes in creating novel cancer therapies.
Where is Inthera Bioscience headquartered?
Inthera Bioscience is headquartered in Zurich, Switzerland.
Which VCs invest in companies like Inthera Bioscience?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Inthera Bioscience's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Inthera Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.